<DOC>
	<DOCNO>NCT02716142</DOCNO>
	<brief_summary>aim study To compare effectiveness rectally administer prostaglandin E1 synthetic analogue ( misoprostol ) 400 microgram versus sublingually administer misoprostol myomectomy decrease blood loss operation .</brief_summary>
	<brief_title>Rectal Misoprostol Versus Sublingual Misoprostol Prior Myomectomy</brief_title>
	<detailed_description />
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Patients present abdominal myomectomy document uterine fibroid pelvic image Age ≥ 18 year ≤ 50 year Preoperative hemoglobin &gt; 8 g/dl Ability understand willingness sign write informed consent . Admissible medical/surgical history Five less symptomatic uterine myoma All myomas subserous intramural . Uterine size le 24 week pregnancy Patients prior abdominal myomectomy Postmenopausal woman Patients known bleeding/clotting disorder Patients history gynecologic malignancy Hypertension . Cardiac Pulmonary disease . Obesity ( body mass index &gt; 30 kg/m2 ) . History allergic reaction attribute misoprostol Cases require intraoperative conversion myomectomy hysterectomy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>